Alliant Energy Corporation vs Vertex Pharmaceuticals Incorporated — how do they compare? Alliant Energy Corporation trades at $68.56 (market cap $17.78B), while Vertex Pharmaceuticals Incorporated trades at $529.62 (market cap $134.25B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 7.6× Alliant Energy Corporation's market cap, and Alliant Energy Corporation pays a 3.12% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals.
| LNT | VRTX | |
|---|---|---|
Market Cap | $17.78B | $134.25B |
Sector | Utilities | Health |
52-Week High | $78.03 | $529.65 |
52-Week Low | $63.62 | $376.62 |
Enterprise Value | $29.88B | $128.37B |
Dividend Yield | 3.12% | — |
Trailing returns across standard periods
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →